Pharmista Technologies ApS: Financial statements 2025
CVR: 44617072
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Pharmista Technologies ApS (CVR 44617072) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -1,810,297 and a net result of DKK -1,929,197 compared with DKK -1,701,491 the year before. Equity in the 2025 report amounted to DKK -3,590,689.
- Gross Profit
- DKK -1,810,297
- Profit/Loss
- DKK -1,929,197
- Equity
- DKK -3,590,689
- Total Assets
- DKK 710,130
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -1.8M | -1.9M | -3.6M | - |
| 2024 | - | -1.6M | -1.7M | -1.7M | 0 |
Official annual report
How creditworthy is Pharmista Technologies ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Pharmista Technologies ApS has published its annual report for 2024. Gross profit came to DKK -1,599,559, and the net result was DKK -1,701,491.
About Pharmista Technologies ApS
Pharmista Technologies ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2024. The company is in liquidation. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Rasmus Lindsten. The company is owned by Pharmista Technologies AB. According to the 2024 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -1,810,297 and a net result of DKK -1,929,197 compared with DKK -1,701,491 the year before. Equity in the 2025 report amounted to DKK -3,590,689.